Proferrin-Forte

Quick links to important sections

Proferrin-Forte

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Proferrin-Forte

Property Description
Active Ingredients Iron, Folic Acid (Vitamin B9), Multivitamin Complex
Form Oral Supplement (Tablet or Capsule)
Pharmacological Class Hematinic Agent, Multivitamin-Mineral Supplement
Common Use Nutritional Support, Replenishing Micronutrient Deficiencies
Origin Synthetically and/or biogenically derived

Proferrin-Forte: Identity and Unique Positioning

Proferrin-Forte is a specialized Fixed-Dose Combination Product, primarily classified as a Hematinic Agent and a comprehensive Multivitamin-Mineral Supplement. As a hematinic, its foundational role is to supply essential cofactors required for supporting the production of blood components, a function clinically recognized for managing nutritional deficiencies. The product, manufactured and distributed by Colorado Biolabs, Inc., distinctively targets individuals requiring high-potency nutritional support, such as pregnant women or patients with diagnosed malabsorption issues. It is supplied as an easy-to-take Oral Supplement (tablet or capsule), making it accessible for nutritional replenishment.

Composition and Evidence-Based Differentiation

The composition centers on three vital active ingredient classes: Iron, Folic Acid (Vitamin B9), and a targeted Multivitamin Complex. A critical differentiating factor is the sourcing of the Iron component, which is frequently presented as Heme Iron Polypeptide (HIP). This specific form demonstrates improved bioavailability and better patient tolerability compared to standard inorganic iron salts; heme iron absorption is often more efficient. Folic Acid is vital for DNA synthesis, while the Multivitamin Complex ensures the presence of cofactors necessary for the efficient metabolic utilization of the primary minerals. The overall purpose of this synergistic formulation is to address simultaneous nutritional shortfalls and support the continuous processes of hemoglobin synthesis and effective red blood cell formation.

What side effects are possible with Proferrin-Forte?

Possible Side Effects

While Proferrin-Forte (Heme Iron Polypeptide and Folic Acid) is generally well-tolerated, particularly when compared to non-heme iron supplements, side effects can still occur. These effects are often mild and gastrointestinal in nature.

Common Side Effects

  • Gastrointestinal discomfort: This may include nausea, upset stomach, diarrhea, constipation, or abdominal pain/cramps.
  • Change in Stool Color: Stools may become dark green or black. This is a common, harmless effect of iron supplements and is not typically a cause for concern.

Serious Side Effects

Contact your healthcare provider immediately or seek emergency medical help if you experience signs of an allergic reaction (such as rash, hives, difficulty breathing, or swelling of the face, lips, tongue, or throat) or signs of a severe iron overdose (which may include vomiting, severe stomach pain, tarry or bloody stools, or collapse).


Warnings and Safety Information

Risk of Accidental Overdose

Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6 years old. Keep Proferrin-Forte out of the reach of children. If a child accidentally takes this medication, contact a poison control center or seek medical care immediately.

Contraindications

This supplement is generally contraindicated for individuals with certain medical conditions, including:

  • Conditions causing iron overload (e.g., hemochromatosis).
  • Certain types of anemia (e.g., pernicious anemia) that are not due to iron deficiency, as taking iron in these cases can be harmful.

Drug Interactions

Proferrin-Forte may interact with other medications, potentially reducing their absorption or effectiveness. Be sure to inform your healthcare providers about all prescription drugs, over-the-counter medicines, and other supplements you are taking. Your iron levels should be monitored regularly by a healthcare professional while on this supplement.

Overdose and Emergency Response

Overdose and When to Seek Help

The official overdose profile for Proferrin-Forte is governed by the acute toxicity of its Iron component, as documented in governmental regulatory sources. Overdose typically presents in phases, beginning with severe gastrointestinal effects that include profuse vomiting (which may contain blood), diarrhea, and significant abdominal pain, sometimes accompanied by bloody or black stools. Systemic effects follow, characterized by clinical signs such as Hypotension (low blood pressure), Tachycardia (rapid heart rate), pallor, and findings of Metabolic Acidosis.

Severe overdose is classified as a potentially life-threatening emergency due to the serious risk of progression to Shock, Acute Liver Failure, and Multisystem Organ Failure. The regulatory requirement is to seek immediate medical attention or contact a Poison Control Center immediately for any suspected overdose. Emergency services must be contacted if manifestations escalate to seizures, loss of consciousness, or trouble breathing.

A critical population-specific regulatory warning highlights that accidental overdose of iron-containing products is a leading cause of fatal poisoning in children younger than 6 years. Documented management procedures include the potential use of the specific chelating agent Deferoxamine for severe systemic toxicity, alongside required supportive care to manage symptoms and maintain physiological stability.

Therapeutic Uses of Proferrin-Forte

What Proferrin-Forte Treats: Main Uses and Benefits

Proferrin-Forte is commonly used to help with symptoms related to systemic imbalance that accompany iron deficiency anemia (IDA) and low systemic iron stores (ferritin deficiency), which may occur alongside a folic acid shortfall. It supports general well-being during symptomatic phases by providing components relevant for addressing the underlying deficiency. Iron and folic acid are relevant components for managing and preventing these deficiency states, particularly in contexts where increased physiological stress or demand is present.

This supplement may be part of symptomatic management for clusters that can accompany anemia, such as persistent chronic fatigue, general physical weakness, and reduced physical endurance. It supports general well-being during symptomatic phases. By contributing to easing the overall symptom load, it may assist with maintaining functional stability and comfort during routine activities.

It is commonly used to help with conditions involving episodic or fluctuating manifestations related to increased physiological demands, such as pregnancy care, or in situations where impaired nutrient absorption is a factor, which may be relevant in chronic gastrointestinal conditions. It is considered relevant in contexts where patients need supportive relief with iron status.

Quick Fact: Relief for Symptoms that Interfere with Daily Functioning
By supporting the body's iron status, Proferrin-Forte may assist with easing the symptoms that interfere with daily functioning and contribute to improved comfort during periods of heightened symptoms.

Regulatory References

  1. World Health Organization (WHO) guidance on Antenatal Iron Supplementation

Eligibility and Restrictions for Use

Proferrin-Forte (Heme Iron Polypeptide and Folic Acid) eligibility is strictly defined by regulatory warnings and contraindications primarily related to iron safety and underlying medical conditions.

Category Regulatory Status
Populations Contraindicated Individuals with iron overload disorders (e.g., hemochromatosis or hemosiderosis) must not use this product.
Condition-Based Exclusions Use is not recommended for patients with pernicious anemia or other anemias not caused by iron or folate deficiency, as the folic acid component can mask the progression of a Vitamin B12 deficiency.
Age-Related Eligibility There is an FDA Warning that accidental overdose of iron-containing products is a leading cause of fatal poisoning in children younger than 6 years of age. Use in the general pediatric population is often not established across all age ranges.
Pregnancy/Lactation Use during pregnancy is generally considered safe when directed by a healthcare provider. Folic acid passes into breast milk; consultation is required to assess the unknown passage of the iron component during lactation.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

Interactions with Proferrin-Forte, an iron and folic acid combination product, are primarily related to the reduction of drug absorption due to chelation or the modification of gastric conditions, and the risk of additive effects.

Pharmacokinetic Interactions (Exposure Modification)

Numerous medications have reduced exposure (bioavailability) when co-administered with iron products, requiring specific timing separation. This effect is documented for several classes, including Quinolone and Tetracycline Antibiotics, Bisphosphonates, Levothyroxine (thyroid hormones), and Levodopa.

Conversely, the absorption of iron itself may be decreased by Antacids, H2 blockers, and Proton Pump Inhibitors (PPIs), which alter stomach pH. Calcium-containing products and Penicillamine can also reduce iron absorption through chelation.

Additive and Population-Specific Considerations

  • Additive Risk: Co-administration with other oral or intravenous iron-containing products increases the risk of iron overload. Combining with other high-dose folic acid supplements is also restricted.
  • Timing Requirement: Regulatory information emphasizes separating the administration of the iron product from interacting medications by two to four hours to mitigate the documented reduction in drug exposure.
  • Special Population Note: Caution is required in patients with Pernicious Anemia, as the folic acid component is documented to potentially mask the hematological signs of Vitamin B12 deficiency.

Mechanism of Action

How Proferrin-Forte Works

Heme-Specific Absorption (HCP1 Pathway)

This mechanism begins with Heme Iron Polypeptide (HIP) uptake through the dedicated HCP1 receptor on intestinal cells. This pathway facilitates the transport of iron into the systemic circulation, utilizing a route distinct from the iron-regulated Non-Heme Iron uptake route. This process supports downstream biological processes requiring elemental iron.

Synchronized Red Blood Cell Production (Erythropoiesis)

The released iron and Folic Acid provide essential co-factor support for the central pathway of erythropoiesis within the bone marrow. Iron is incorporated into hemoglobin structure, while Folic Acid acts as a co-factor in the one-carbon metabolism pathway necessary for DNA synthesis and proliferation of erythroid cells. The combined action supports the development of red blood cell precursors.

Resulting Systemic Oxygen Transport Effect

The formation of new, hemoglobin-rich red blood cells elevates the blood’s total oxygen-carrying capacity. This systemic effect results from the preceding mechanistic cascades and facilitates oxygen delivery to body tissues, which supports key cellular functions, including mitochondrial energy production.

Dosage and Administration Information

How to Use Proferrin-Forte

Administration of Proferrin-Forte follows usage principles established for its combined components: Heme Iron Polypeptide and Folic Acid. The entire use protocol is structured around a descriptive overview of the route, dosing ranges, and mandatory administration conditions.


Administration Scope

Instruction Detail
Route of administration Oral (taken by mouth).
Dosing schedule (Adults) The typical dose is one tablet, with a prescribed frequency ranging from once daily to twice daily, and potentially up to three times daily. The final dosage is determined by individual patient requirements.
Timing in relation to meals The tablet may be taken with or without meals, a feature noted for heme iron compounds.
Preparation requirements Must be swallowed with a full glass (8 ounces or 240 ml) of water.
Age-group use rules Pediatric Use: Administration to children is only as directed by a physician. Pregnancy: Use is considered safe when taken as directed by a physician.
Missed-dose rules If a dose is missed and the next scheduled dose is approaching, the instruction is to skip the missed dose and resume the regular schedule. Doses should not be doubled to compensate.
Special procedural conditions The user should remain upright and avoid lying down for at least 10 minutes after administration to ensure proper passage of the tablet. Treatment duration is maintained until the targeted replenishment of iron stores is achieved, which may involve periodic laboratory monitoring.

Procedural Structure

The established protocol defines the consistent use of the oral route and the fixed unit strength, structuring the administration around a flexible daily frequency. The protocol mandates specific constraints, including the required fluid volume and a temporary postural instruction following intake.

Recent Clinical Evidence

The research evidence for Proferrin-Forte's active ingredients—primarily Heme Iron Polypeptide (HIP) and Folic Acid—has been explored through various clinical trials and systematic reviews examining specific patient populations.


Evidence for Use in Iron Deficiency and Low Iron Stores

Research has explored the use of the Heme Iron Polypeptide component in adults experiencing iron deficiency anemia (IDA) and low iron stores. Studies, including Randomized Controlled Trials (RCTs), examined key hematological biomarkers (Hemoglobin and Ferritin) and patient-reported experiences like gastrointestinal side effects. Findings describe patterns observed in these studies, sometimes describing different GI event profiles compared to standard iron salts. However, the overall evidence quality varies, and the certainty of evidence for superior efficacy compared to non-heme iron remains low in some formal systematic reviews.


Evidence for Use in Anemia During Pregnancy

Research has focused on the supplement's use in pregnant women, a population with significantly increased iron and folic acid requirements. Studies monitored maternal blood parameters (such as Hemoglobin and Ferritin) and tracked patient adherence and compliance. Studies reported measurements of patient adherence, with findings describing patterns observed in the study period. Despite this, the long-term follow-up data for maternal iron status postpartum is not consistently tracked, and the existing research is often based on smaller cohorts.


Evidence for Use in Patients with Chronic Kidney Disease (CKD)

The oral Heme Iron Polypeptide component was evaluated in a specialized group of adults with Non-Dialysis Chronic Kidney Disease (ND-CKD) who experience iron deficiency anemia. Comparative trials monitored Hemoglobin concentrations and shifts in iron indices (Ferritin, Transferrin Saturation) when compared to treatments like intravenous iron. Systematic reviews have described the data as suggesting that the heme iron component may not consistently offer a clear advantage over traditional oral iron supplementation in this research setting.


Research Gaps and Uncertainty

Research typically used intermediate follow-up periods, usually ranging from 4 weeks up to 6 months. Data are still emerging, and long-term effects and the durability of iron status maintenance are not fully established. Additionally, data for certain specialized populations, such as children or those with gastrointestinal conditions, remain insufficient for broad conclusions, and the certainty of comparative evidence is generally limited.

Key Studies & References

  1. WHO Guidelines on Antenatal Iron and Folic Acid Supplementation

Frequently Asked Questions (FAQ)

Common questions about Proferrin-Forte (FAQ)


Q: Does Proferrin-Forte typically cause less constipation or stomach upset than standard iron supplements?

Studies have examined the Heme Iron Polypeptide (HIP) component, which is different from non-heme iron salts like ferrous sulfate. According to research, HIP may result in fewer gastrointestinal side effects such as constipation or stomach upset. This improved tolerability profile is a factor that may be considered when discussing iron supplementation options with a healthcare provider.


Q: Can Proferrin-Forte be taken if a person has a sensitive stomach or a history of nausea with iron?

The product contains Heme Iron Polypeptide, a form of iron that some studies have associated with a lower rate of gastrointestinal (GI) side effects compared to conventional iron salts. The improved tolerability profile of Heme Iron Polypeptide compared to conventional iron salts has been noted in studies. Individuals with concerns about previous GI issues should consult their healthcare provider.


Q: Is Proferrin-Forte safe for use during pregnancy, based on official information?

Official product information confirms that Proferrin-Forte, which contains iron and folic acid, is generally considered appropriate for use during pregnancy. Consultation with a healthcare provider is generally required to determine its appropriate use.


Q: How long does it typically take to see an improvement in lab values (like ferritin) after starting Proferrin-Forte?

The goal of using the product is to replenish the body’s iron stores, a process that is typically monitored through periodic laboratory testing of iron markers. Clinical guidance indicates that the period required to restore iron stores may span several months. The duration of use is determined by a healthcare provider.


Q: Does Proferrin-Forte have any known major or moderate drug interactions that patients should be aware of?

Regulatory documentation lists various drug interactions where the iron component may reduce the absorption or exposure of the other drug. These include medications such as Quinolone and Tetracycline Antibiotics, Levothyroxine, and certain bone density treatments. Official information outlines requirements for the timing of administration to ensure separation from other drugs, typically by several hours.


Q: Is it necessary to take Vitamin C along with Proferrin-Forte to ensure proper absorption?

The absorption of Heme Iron Polypeptide (HIP) is described as less affected by common dietary factors than non-heme iron salts. Therefore, HIP does not typically require co-administration with Vitamin C to optimize its absorption pathway.


Q: What is the risk profile of heme iron compared to ferrous sulfate, according to research?

Studies comparing Heme Iron Polypeptide (HIP) to non-heme iron salts, such as ferrous sulfate, have described different gastrointestinal event profiles for the HIP component. This is often related to a reduced reported incidence of common GI side effects, such as nausea or constipation, according to the research evidence.


Q: Is Proferrin-Forte considered a prescription drug or an over-the-counter (OTC) supplement in most regions?

Proferrin-Forte is classified as a Dietary Supplement that may be available in the market as either an over-the-counter (OTC) product or a prescription-strength product. Its regulatory status and availability can vary depending on the region.


Q: What is the elemental iron content in one tablet of Proferrin-Forte?

According to the product label, one tablet of Proferrin-Forte contains 12 mg of elemental iron. This iron is derived from the Heme Iron Polypeptide component. The formulation also includes 1 mg of Folic Acid.


Q: Is there any research evidence that supports Proferrin-Forte's effectiveness for low iron levels?

Research has explored the use of the Heme Iron Polypeptide component in adults with iron deficiency anemia (IDA). Studies, including Randomized Controlled Trials (RCTs), have been conducted to examine key blood and iron biomarkers to assess the effect on iron status.


Q: Is the iron source in Proferrin-Forte derived from animal products, and what type of animal is it?

The Heme Iron Polypeptide component is derived from animal-based sources. Heme iron typically originates from animal tissues such as red meat, poultry, or seafood.


Q: If someone is a vegetarian or vegan, are there concerns about the source of Proferrin-Forte?

Given that Heme Iron Polypeptide is derived from animal sources, the product is generally not suitable for individuals who follow strictly vegetarian or vegan diets.


Q: Is the absorption mechanism of heme iron different from non-heme iron?

Yes, the mechanisms of absorption are different. Heme iron is taken up through a dedicated pathway involving the HCP1 receptor on the intestinal cells. This specific route is distinct from the way the body absorbs non-heme iron.


Q: Is a metallic taste in the mouth a commonly reported side effect when taking Proferrin-Forte?

A metallic taste in the mouth is sometimes mentioned as a side effect that can occur with iron supplementation. This is generally noted as a common side effect of iron products. Individuals should consult a healthcare provider if this effect is persistent or concerning.


Q: Are there different strengths or formulations of Proferrin-Forte available?

The manufacturer offers different formulations under the Proferrin brand. One example is Proferrin-ES, which is a different product that typically contains the Heme Iron Polypeptide but may not include the Folic Acid component found in Proferrin-Forte.


Q: What is the difference between Proferrin-Forte and Proferrin-ES?

Proferrin-Forte is a fixed-dose combination product that includes both Heme Iron Polypeptide (12 mg elemental iron) and Folic Acid (1 mg). Proferrin-ES is a separate formulation that typically contains the Heme Iron Polypeptide but does not contain the Folic Acid component.


Q: What kind of scientific studies have been conducted on Heme Iron Polypeptide?

Research conducted on the Heme Iron Polypeptide component includes Randomized Controlled Trials (RCTs) and Systematic Reviews. These studies evaluate the component’s impact on key blood markers, such as Hemoglobin and Ferritin, in specific patient populations.


Q: Is Proferrin-Forte used to treat all types of anemia, or only specific kinds?

Proferrin-Forte is intended to address the body's requirements for iron and folic acid. Official warnings note that the product is not recommended for certain types of anemia, specifically those that are not caused by an iron or folate deficiency, such as pernicious anemia.


Q: Does taking Proferrin-Forte impact kidney function in any way?

The Heme Iron Polypeptide component has been evaluated in research involving patients with Non-Dialysis Chronic Kidney Disease (ND-CKD) who experience iron deficiency anemia. Individuals with known kidney disease are advised in official documentation to consult a healthcare provider before use.


Q: Can Proferrin-Forte affect a person's appetite or cause weight changes?

Iron deficiency itself can sometimes be associated with a change in appetite, which may be restored once iron supplementation begins. The official product safety information does not generally list significant changes in weight as a common or serious side effect.


Q: Are there any known interactions between Proferrin-Forte and common vitamins or supplements, like Vitamin C or Zinc?

The interaction profile highlights that certain supplements, particularly those containing calcium or other multivalent cations (minerals with a positive charge), can reduce the absorption of the iron component. For this reason, official guidance recommends separating the administration of Proferrin-Forte from these types of supplements.


Q: Is there a maximum recommended period for taking Proferrin-Forte continuously?

The duration of use is guided by the goal of replenishing the body's iron stores. This often requires periodic blood work and monitoring. As directed by a healthcare provider, continuous use typically lasts until the stores are fully restored, which may take several months.


Q: Can Proferrin-Forte be taken by older adults (seniors)?

Official documentation does not list older adults as a population that is specifically excluded from use. The general adult use rules apply, assuming the individual does not have any underlying health conditions that would contraindicate iron or folic acid supplementation.


Q: What happens if a person takes more Proferrin-Forte than the amount described in their instructions?

Taking more than the amount directed increases the risk of iron overload, which can lead to acute iron poisoning. Official warnings state that accidental overdose of iron-containing products can be fatal, especially in children. In the event of an overdose, contact a poison control center or seek emergency medical care immediately.


Q: Can Proferrin-Forte interfere with the results of any common lab tests?

Iron supplements can affect the results of certain medical tests. For example, the Folic Acid component is noted in regulatory information to potentially mask the blood-related signs of Vitamin B12 deficiency, known as pernicious anemia. Individuals preparing for laboratory testing should provide information about all supplements, including this product, to their healthcare provider.

How should Proferrin-Forte be stored and disposed of?

How to Store and Dispose of Proferrin-Forte?

Proferrin-Forte must be stored under specific conditions to maintain its stability. The product requires room temperature storage, maintaining a range between 59°F and 86°F (15°C and 30°C).


Storage Requirements

  • The tablets must be protected from light and moisture; therefore, storage in high-humidity areas like the bathroom is prohibited.
  • Due to its iron content, which poses a serious poisoning risk, the medicine must be kept out of the reach of children and pets.

Disposal Instructions

Unused or expired tablets must be discarded properly. Regulatory guidelines require that the medicine not be flushed down a toilet or poured into a drain unless explicitly authorized. Consult a pharmacist or local waste disposal service for guidance on safe disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Proferrin-Forte found in:

A-Z Index: